Palavras-chave
intervenções comportamentais
terapias baseadas em jogo
intervenções farmacológicas
desenvolvimento infantil
Como Citar
Resumo
O Transtorno do Espectro Autista (TEA) é uma condição neurodesenvolvimental que afeta a comunicação social e comportamentos repetitivos ou restritos. Com uma prevalência crescente, a necessidade de entender e intervir de forma eficaz no TEA é urgente. Esta revisão foca nos avanços recentes relacionados ao entendimento do desenvolvimento infantil em crianças com TEA e as subsequentes implicações clínicas e terapêuticas. Intervenções comportamentais continuam a ser a espinha dorsal do tratamento, com abordagens intensivas e bem-estruturadas demonstrando melhorias em áreas como comunicação e habilidades sociais. No entanto, terapias baseadas em jogo têm ganhado destaque, proporcionando ambientes naturais para desenvolvimento social. Paralelamente, o campo das intervenções farmacológicas tem evoluído, visando tratar sintomas específicos e comorbidades associadas ao TEA. Apesar das promissoras abordagens individualizadas, combinar múltiplas intervenções se mostra mais eficaz, considerando a natureza multifacetada do TEA. As pesquisas futuras devem continuar focando em tratamentos individualizados e baseados em evidências, com ênfase em uma compreensão profunda dos mecanismos neurobiológicos subjacentes e avaliação de longo prazo das intervenções.Referências
AMERICAN PSYCHIATRIC ASSOCIATION. (2013). Manual Diagnóstico e Estatístico de Transtornos Mentais (DSM-5). Artmed.
CASE-SMITH, J., & ARBESMAN, M. (2008). Evidence-based review of interventions for autism used in or of relevance to occupational therapy. The American Journal of Occupational Therapy, 62(4), 416-429.
COOPER, J.O., HERON, T.E., & HEWARD, W.L. (2007). Applied Behavior Analysis (2nd ed.). Upper Saddle River, NJ: Pearson.
DAWSON, G., ROGERS, S., MUNSON, J., SMITH, M., WINTER, J., GREENSON, J., ... & VARLEY, J. (2010). Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics, 125(1), e17-e23.
ERICKSON, C. A., WINK, L. K., RAY, B., EARLY, M. C., STIEGELMEYER, E., MATHIEU-FRASIER, L., ... & LAHIRI, D. K. (2017). Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome. Psychopharmacology, 234(14), 2151-2162.
GERSCHWIND, D. H., & LEVITT, P. (2007). Autism spectrum disorders: developmental disconnection syndromes. Current Opinion in Neurobiology, 17(1), 103-111.
GREEN, J., ALDRED, C., CHARMAN, T., LE COUTEUR, A., EMSLEY, R. A., GRAHAME, V., ... & LANDAU, S. (2017). Paediatric Autism Communication Therapy-Generalised (PACT-G) against treatment as usual for reducing symptom severity in young children with autism spectrum disorder: study protocol for a randomised controlled trial. Trials, 18(1), 1-12.
HANDEN, B. L., AMAN, M. G., ARNOLD, L. E., HYMAN, S. L., TUMULURU, R. V., LECVALIER, L., ... & SWIEZY, N. B. (2015). Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 54(11), 905-915.
HOWARD, J.S., SPARKMAN, C.R., COHEN, H.G., GREEN, G., & STANISLAW, H. (2005). A comparison of intensive behavior analytic and eclectic treatments for young children with autism. Research in Developmental Disabilities, 26(4), 359-383.
HOWLIN, P., MAGIATI, I., & CHARMAN, T. (2014). Systematic review of early intensive behavioral interventions for children with autism. American Journal on Intellectual and Developmental Disabilities, 119(1), 23-41.
KING, B. H., HOLLANDER, E., SIKICH, L., MCCRACKEN, J. T., SCAHILL, L., BREGMAN, J. D., ... & RITZ, L. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry, 66(6), 583-590.
LEAF, J.B., LEAF, R., MCEACHIN, J., TAUBMAN, M., ALA'I-ROSALES, S., ROSS, R.K., ... & WEISS, M.J. (2016). Applied behavior analysis is a science and, therefore, progressive. Journal of Autism and Developmental Disorders, 46(2), 720-731.
LINDERMAN, T. M., & STEWART, K. B. (2016). Play-based interventions for children and adolescents with autism spectrum disorders. Journal of Childhood & Developmental Disorders, 2(2), 1-7.
LOVAAS, O.I. (1987). Behavioral treatment and normal educational and intellectual functioning in young autistic children. Journal of Consulting and Clinical Psychology, 55(1), 3-9.
MAENNER, M. J., SHAW, K. A., BAIO, J., WASHINGTON, A., PATRICK, M., DIRIENZO, M., ... & DIETZ, P. M. (2020). Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2016. MMWR Surveillance Summaries, 69(4), 1.
MARCUS, R. N., OWEN, R., KAMEN, L., MANOS, G., MCQUADE, R. D., CARSON, W. H., & AMAN, M. G. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 48(11), 1110-1119.
MCCOY, R., BARTLEY, G., & MANASCO, H. (2019). Pharmacotherapies for developmental disabilities. Pharmacy Practice News, 46(7), 16-21.
MCPHEETERS, M. L., WARREN, Z., SATHE, N., BRUZEK, J. L., KRISHNASWAMI, S., JEROME, R. N., & VEENSTRA-VANDERWEELE, J. (2011). A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 127(5), e1312-e1321.
MUNDY, P., & CROWSON, M. (1997). Joint attention and early social communication: Implications for research on intervention with autism. Journal of Autism and Developmental Disorders, 27(6), 653-676.
OWEN, R., SIKICH, L., MARCUS, R. N., COREY-LISLE, P., MANOS, G., MCQUADE, R. D., ... & FINDLING, R. L. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124(6), 1533-1540.
PIAGET, J. (1962). Play, dreams and imitation in childhood. New York: Norton.
ROGERS, S. J., ESTES, A., LORD, C., VISMARA, L., WINTER, J., FITZPATRICK, A., ... & DAWSON, G. (2012). Effects of a brief Early Start Denver model (ESDM)–based parent intervention on toddlers at risk for autism spectrum disorders: A randomized controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 51(10), 1052-1065.
SCHAEFER, C. E., & DREWES, A. A. (2014). The therapeutic powers of play: 20 core agents of change. John Wiley & Sons.
SIEGEL, M., & BEAULIEU, A. A. (2012). Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice. Journal of Autism and Developmental Disorders, 42(8), 1592-1605.
SOLOMON, R., NECHELES, J., FERCH, C., & BRUCKMAN, D. (2007). Pilot study of a parent training program for young children with autism: The PLAY Project Home Consultation program. Autism, 11(3), 205-224.
WARREN, Z., MCPHEETERS, M. L., SATHE, N., FOSS-FEIG, J. H., GLASSER, A., & VEENSTRA-VANDERWEELE, J. (2011). A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics, 127(5), e1303-e1311.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Luiza Nunes da Costa , Maria Vitoria Manfio Herzog , Maria Julia Gomes Ferreira Santos , Arthur Junqueira Ferreira Santos , Paula Sayuri Tsugao , Bruna Torrezan Marin, Bruna Amaral Dal Mas , Verônica de Souza Martins , Lucas Lopes Malveira, Hemily de Oliveira Celestino , João César Almeida Merçon , Ana Carolina Diniz e Padua , Nádia Oliveira Cabral , Skarlett Ribeiro Raitez, Arthur Henrique Santos Veloso , Rafaianne Santos Veloso, Luiz Fernando Lopes Teixeira